🇺🇸 FDA
Patent

US 11077200

Combined enteropathogen recombinant construct

granted A61KA61K2039/55505A61K2039/6037

Quick answer

US patent 11077200 (Combined enteropathogen recombinant construct) held by United States of America as represented by the Secretary of the Air Force expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/55505, A61K2039/6037, A61K2039/70, A61K39/00